Business
Issue of Equity and PDMR Dealings
Issue of Equity and PDMR Dealings.
About this update from Journeo Plc
[{"type":"text","content":"\n\n23 January 2025\nJourneo plc\n(\"Journeo\", or the \"Company\")\n \nIssue of Equity and PDMR Dealings\nJourneo plc (AIM: JNEO), a leading provider of information systems and technical services to transport operators and local authorities announces the issuance of a total of 477,187 new ordinary shares of 6.5p each (\"Ordinary Shares\") pursuant to the exercise of options by certain employees and PDMRs, as well as other PDMR dealings.\nPursuant to the Company's 2020 EMI scheme, options have been exercised over 153,334 new Ordinary Shares by certain employees at an exercise price of 50p per share, including 50,000 by Nick Lowe, Chief Financial Officer, who has undertaken a partial exercise of his total EMI options held. Nick subsequently sold 50,000 Ordinary Shares at 272p per share.\nFurthermore, Russ Singleton, Chief Executive Officer, has exercised a put option granted to him under the Company's Employee Shareholder plan (the \"Plan\"), further details of which were announced by the Company on 28 November 2014 and was approved by shareholders on 17 December 2014. The Plan entitled Russ to an award of value, either in cash or shares, subject to the achievement of a minimum share price at the time of exercise. With the relevant share price hurdle having been met, the board has determined at its discretion that the award due to Russ following this exercise shall be satisfied through the issue of 323,853 new Ordinary Shares. The Company announces that following this exercise, Russ subsequently sold 166,666 Ordinary Shares at a price of 272p per share. Following these transactions, Russ's beneficial interest has increased to 622,572 Ordinary Shares, representing approximately 3.67 per cent. of the Company's enlarged issued share capital. \nApplication has been made for 477,187 new Ordinary Shares to be admitted to trading on AIM (\"Admission\") and it is expected that Admission will occur on 29 January 2025. Following Admission, the Company will have 16,951,678 Ordinary Shares in issue. The Company holds no shares in treasury. Accordingly, the total number of voting rights in the Company following Admission will be 16,951,678. This figure should be used by Shareholders as the denominator for calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, Ordi...